Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Impressive preliminary results.

<< Previous

Bullboard Posts

Next >>

Post by wildbird1on Jun 24, 2022 7:40am

432 Views

Post# 34779536

Impressive preliminary results.

In this last press release...
Dr.Arkady Mandel said" The success in the Phase 1b NMIBC clinical study has led to the impressive preliminary results demonstrated in the Phase11 NMIBC clinical study, focused primarily on efficacy and secondarily on safety. In the future, I foresee great potential for TLT Anti-Cancer Therapy to deliver a safe and effective anti cancer treatment for numerous cancer indications with high unmet needs.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project